Usefulness of combining universal oligonucleotides in detecting human papillomavirus in cervical cancer and premalignant lesions

被引:16
作者
Carrillo, A [1 ]
Mohar, A [1 ]
Meneses, A [1 ]
Frías-Mendivil, M [1 ]
Solorza, G [1 ]
Lizano, M [1 ]
机构
[1] Inst Nacl Cancerol, Subdirecc Invest Basica, Mexico City 14080, DF, Mexico
来源
SALUD PUBLICA DE MEXICO | 2004年 / 46卷 / 01期
关键词
HVP; cervical cancer; PCR; primers; Mexico;
D O I
10.1590/S0036-36342004000100002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
Objective. To determine the prevalence of human papillomavirus (HPV) infection at different stages of the natural history of cervical cancer. Also, to optimize its detection by means of different sets of general primers. Material and Methods. A descriptive, cross-sectional study was conducted between January and December 1999. Samples were processed and analyzed at the Instituto Nacional de Cancerologia (National Cancerology Institute) in Mexico City. A comparative analysis was performed using Student's t for continuous values and the chi-squared test for proportions. A contingency analysis was made between biopsy and cervical exudates with the Kappa statistic. HPV detection was done by PCR with general primers which recognize different regions of the L I gene (MY09/11; GP5/6; L1C1/2) and with HPV16- and HPV18- specific primers, as well as direct sequencing of PCR products. Results. In total, 154 samples were analyzed: 65 (42.2%) of them showed normal cytology; 45 (29.2%) high and low grade lesions; and 44 (28.6%) invasive cervical cancer. HPV was detected in 95.5% of invasive cervical cancers, in 91.6% of high grade lesions, in 66.7% of low grade lesions, and in 23.1% of normal smears, by PCR with at least one set of oligonucleotide primers. HPV detection was more efficient in biopsy specimens than in cervical scrapes. The total percentage of HPV detection using only one set of universal oligonucleotides (37.6%)increased to 60.4% when the other two sets of universal oligonucleotides were used. Conclusions. The frequency of high risk HPV is high even in women with reported normal cytology. HPV detection improves when different sets of general primers directed to the L1 region are used. HPV DNA screening in cervical scrapes may be a good alternative HPV diagnostic tool when the samples are appropriately taken. The English version of this paper is available at: http://www.insp.mx/salud/index.html.
引用
收藏
页码:7 / 15
页数:9
相关论文
共 66 条
[1]
GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN FEMALE UNIVERSITY-STUDENTS AS DETERMINED BY A PCR-BASED METHOD [J].
BAUER, HM ;
TING, Y ;
GREER, CE ;
CHAMBERS, JC ;
TASHIRO, CJ ;
CHIMERA, J ;
REINGOLD, A ;
MANOS, MM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04) :472-477
[2]
GENOME AMPLIFICATION OF HUMAN PAPILLOMAVIRUS TYPES 16 AND 18 IN CERVICAL CARCINOMAS IS RELATED TO THE RETENTION OF E1/E2 GENES [J].
BERUMEN, J ;
CASAS, L ;
SEGURA, E ;
AMEZCUA, JL ;
GARCIACARRANCA, A .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (05) :640-645
[3]
Berumen J, 1997, Gac Med Mex, V133 Suppl 1, P35
[4]
Recombinant therapeutic vaccines against invasive cervical cancer. [J].
Berumen, J ;
Villegas, N .
SALUD PUBLICA DE MEXICO, 1997, 39 (04) :288-297
[5]
PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[6]
Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment [J].
Cornelison, TL .
CURRENT OPINION IN ONCOLOGY, 2000, 12 (05) :466-473
[7]
HUMAN PAPILLOMAVIRUS AND INVASIVE CERVICAL-CANCER IN BRAZIL [J].
ELUFNETO, J ;
BOOTH, M ;
MUNOZ, N ;
BOSCH, FX ;
MEIJER, CJLM ;
WALBOOMERS, JMM .
BRITISH JOURNAL OF CANCER, 1994, 69 (01) :114-119
[8]
Flores Y, 2002, SALUD PUBLICA MEXICO, V44, P335
[9]
Gariglio P, 1998, ARCH MED RES, V29, P279
[10]
GONZALEZGARAY ML, 1992, REV INVEST CLIN, V44, P491